GlaxoSmithKline And Merck KGaA Position For The Next Wave In Immuno-Oncology
GlaxoSmithKline And Merck KGaA Position For The Next Wave In Immuno-Oncology.....»»
Exelixis enters STELLAR-001 pact, supply agreement with Merck KGaA and Pfizer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
I-MAB launches discovery initiative to expand immuno-oncology pipeline
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Surface Oncology, Merck to collaborate on study evaluating SRF388 with KEYTRUDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Takeda To Expand Immuno-Oncology Portfolio With Maverick Therapeutics Acquisition
Takeda Pharmaceutical Co Ltd (NYSE: TAK) has read more.....»»
Merck KGaA price target lowered to EUR 141 from EUR 143 at Morgan Stanley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA price target raised to EUR 140 from EUR 130 at Barclays
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA initiated with a Hold at Berenberg
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Longevity announces 4D trial collaboration with Pfizer and Merck KGaA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA price target raised to EUR 143 from EUR 141 at Morgan Stanley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA announces FDA approval of Tepmetko in metastatic lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA reports 5.4% passive stake in F-star Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer, Merck KGaA announce EC approval of Bavencio for UC patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA discontinues clinical trial for bintrafusp alfa in lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA price target raised to EUR 141 from EUR 138 at Morgan Stanley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA upgraded to Overweight from Neutral at JPMorgan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Surface Oncology announces license agreement with GlaxoSmithKline for SRF813
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA downgraded to Hold from Buy at Nord/LB
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA says profit could slip as fertility treatments shunned
Merck KGaA said a slight decline in operating earnings was on the cards this year as the coronavirus pandemic weighs on demand for chemicals in TV screens and is putting couples off seeking the German group's fertility treatments......»»
Merck KGaA price target lowered to EUR 110 from EUR 115 at Deutsche Bank
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA price target lowered to EUR 90 from EUR 94 at Barclays
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»